ATMP

The regulatory requirements fo ATMPs are well known by Valicare experts

ATMP, the shortcut for “advanced therapy medicinal product”, stands for revolutionary innovations in medical treatment. The market for these novel therapeutics is strongly increasing.They are defined through the guideline 2003/63/EG and comprise gene therapy, somatic cell therapy and tissue engineering.

ATMPs have a big potential for treatment of cancers, metabolic, viral and autoimmune diseases and the expectations are very high that they will be effective where conventional approaches fail. The production of ATMPs is controlled by pharmaceutical law (AMG), the EU GMP guideline and special directives.

We work on GMP requirements for drug manufacturing for over 15 years now. Meanwhile we can offer you an extensive GMP service portfolio. But ATMPs need also special product-specific GMP solutions. Some of our GMP consultants are highly specialized in ATMPs and they are also very close to research and development.

They know the actual directives for ATMPs very well and can support you with technical and scientific expertise on the highest level. We are pleased to accompany you on the way to the GMP-compliant production of your ATMP.

Look here what kind of GMP for ATMPs services and about current news around ATMP.

 

Contact us if you have any questions. We will gladly answer and advise you.

We process / use your data for contacting, registration and for execution of of the above training. By clicking on this box you accept these terms of use.

Further information can be found in our privacy statement.